Shares of Semler Scientific, Inc. (NASDAQ:SMLR - Get Free Report) fell 6.1% on Tuesday . The company traded as low as $54.74 and last traded at $55.36. 133,518 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 359,435 shares. The stock had previously closed at $58.94.
Semler Scientific Trading Down 6.3 %
The company has a market cap of $511.91 million, a P/E ratio of 26.95 and a beta of 1.18. The company has a 50 day moving average price of $55.94 and a 200-day moving average price of $38.21.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.35. The company had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.
Hedge Funds Weigh In On Semler Scientific
A number of institutional investors and hedge funds have recently bought and sold shares of the company. Newbridge Financial Services Group Inc. bought a new stake in shares of Semler Scientific during the second quarter worth about $34,000. Quest Partners LLC bought a new stake in Semler Scientific during the 2nd quarter worth approximately $59,000. Meeder Asset Management Inc. acquired a new position in Semler Scientific in the 2nd quarter valued at approximately $67,000. US Bancorp DE raised its stake in shares of Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company's stock valued at $72,000 after acquiring an additional 1,158 shares during the last quarter. Finally, Sanctuary Advisors LLC acquired a new position in shares of Semler Scientific during the third quarter worth $104,000. Institutional investors and hedge funds own 49.37% of the company's stock.
Semler Scientific Company Profile
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Stories
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
